Özcan Met
Impact in
- Immunology top 1%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
- Immune cells in cancer
- Oncology top 1%
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
Papers in
- Immunology 59
- Immunotherapy and Immune Responses 44
- Immune Cell Function and Interaction 22
- T-cell and B-cell Immunology 9
- Immune cells in cancer 6
- Oncology 56
- CAR-T cell therapy research 41
- Cancer Immunotherapy and Biomarkers 28
- Co-authors
- Inge Marie Svane (74 shared papers)Marco Donia (34 shared papers)Cathrine Lund Lorentzen (3 shared papers)John B.A.G. Haanen (2 shared papers)Mads Hald Andersen (29 shared papers)Per thor Straten (25 shared papers)Troels Holz Borch (21 shared papers)Christopher A. Chamberlain (9 shared papers)
- Journals
- OncoImmunology (17 papers)Annals of Oncology (6 papers)Journal for ImmunoTherapy of Cancer (6 papers)Cytotherapy (4 papers)Frontiers in Immunology (4 papers)
- Partner nations
- DenmarkNetherlandsUnited States
In The Last Decade
Özcan Met
88 papers receiving 2.9k citations
Özcan Met's Hit Papers
Peers
Comparison fields: 5 of 97
- Immunology 1.6k
- Oncology 1.7k
- Molecular Biology 837
- Biotechnology 105
- Biological Psychiatry 25
Countries citing papers authored by Özcan Met
This map shows the geographic impact of Özcan Met's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Özcan Met with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Özcan Met more than expected).
Fields of papers citing papers by Özcan Met
This network shows the impact of papers produced by Özcan Met. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Özcan Met. The network helps show where Özcan Met may publish in the future.
Co-authors
The 25 scholars most cited alongside Özcan Met, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 94 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Clinical advances and ongoing trials of mRNA vaccines for cancer treatment Hit paper breakdown → | 2022 | 369 |
| 2 | 2016 | 237 | |
| 3 | 2018 | 162 | |
| 4 | 2012 | 136 | |
| 5 | 2018 | 90 | |
| 6 | 2020 | 79 | |
| 7 | 2014 | 76 | |
| 8 | 2017 | 72 | |
| 9 | 2017 | 69 | |
| 10 | 2018 | 68 | |
| 11 | 2020 | 64 | |
| 12 | 2013 | 61 | |
| 13 | 2018 | 58 | |
| 14 | 2022 | 57 | |
| 15 | 2016 | 56 | |
| 16 | 2018 | 52 | |
| 17 | 2022 | 52 | |
| 18 | 2021 | 50 | |
| 19 | 2020 | 50 | |
| 20 | 2013 | 48 |
About Özcan Met
Özcan Met is a scholar working on Immunology, Oncology, Molecular Biology, Genetics and Biomedical Engineering, having authored 94 papers that have together received 3.0k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (44 papers), CAR-T cell therapy research (41 papers), Cancer Immunotherapy and Biomarkers (28 papers), Immune Cell Function and Interaction (22 papers), T-cell and B-cell Immunology (9 papers), vaccines and immunoinformatics approaches (7 papers), RNA Interference and Gene Delivery (6 papers) and Immune cells in cancer (6 papers). The work is most often cited by research in Immunology (1.6k citations), Oncology (1.7k citations), Molecular Biology (837 citations), Biotechnology (105 citations) and Biological Psychiatry (25 citations). Özcan Met has collaborated with scholars based in Denmark, Netherlands and United States. Frequent co-authors include Inge Marie Svane, Marco Donia, Cathrine Lund Lorentzen, John B.A.G. Haanen, Mads Hald Andersen, Per thor Straten, Troels Holz Borch, Christopher A. Chamberlain, Rikke Andersen and Eva Ellebæk. Their work appears in journals such as OncoImmunology, Annals of Oncology, Journal for ImmunoTherapy of Cancer, Cytotherapy and Frontiers in Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.